13023_2015_311_MOESM1_ESM.tif (1.24 MB)
Additional file 1: of Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy
figure
posted on 2015-08-22, 05:00 authored by Daniela Miglietta, Clara De Palma, Clara Sciorati, Barbara Vergani, Viviana Pisa, Antonello Villa, Ennio Ongini, Emilio ClementiNaproxcinod administration does not alter body weight and food intake in mdx mice. (a) Body weight and (b) food intake of mdx mice treated with vehicle (closed circles), naproxen at 20 mg/kg (grey triangles), or naproxcinod at 30 mg/kg (open squares) were monitored every week for 5 months. Data are presented as mean ± SEM. N = 8-10 mice/group. (TIFF 1270 kb)